BioMed Realty Trust's total inventories for the quarter that ended in Sep. 2015 was $0.0 Mil. BioMed Realty Trust's average total inventories from the quarter that ended in Jun. 2015 to the quarter that ended in Sep. 2015 was $0.0 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. BioMed Realty Trust's Net-Net Working Capital per share for the quarter that ended in Sep. 2015 was $-16.13.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
BioMed Realty Trust's Days Inventory for the
three
months ended in Sep. 2015 was 0.00.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioMed Realty Trust's Inventory-to-Revenue for the quarter that ended in Sep. 2015 was 0.00.
BioMed Realty Trust Total Inventories Historical Data
The historical data trend for BioMed Realty Trust's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
BioMed Realty Trust (NYSE:BMR) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
BioMed Realty Trust's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2015 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioMed Realty Trust's Inventory to Revenue for the quarter that ended in Sep. 2015 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
BioMed Realty Trust Total Inventories Related Terms
Thank you for viewing the detailed overview of BioMed Realty Trust's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.
BioMed Realty Trust (BioMed Realty Trust) Business Description
BioMed Realty Trust Inc, a Maryland corporation was formed on April 30, 2004 and commenced operations on August 11, 2004, after completing its initial public offering. The Company operates as a self-administered and self-managed real estate investment trust focused on acquiring, developing, owning, leasing and managing laboratory and office space for the life science industry mainly through its subsidiary, BioMed Realty, L.P., a Maryland limited partnership Its tenants mainly include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are generally located in markets with well established reputations as centers for scientific research, including Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/ New Jersey. The Company faces competition from various entities for investment opportunities in properties for life science tenants, including other REITs, such as health care REITs and suburban office property REITs, pension funds, insurance companies, investment funds and companies, partnerships, and developers. The Company's properties are subject to various laws, ordinances and regulations, including regulations relating to common areas.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BMR has been successfully added to your 